US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Mar 17, 2026 (6 months ago)

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

What was recalled

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9262-08.

Recalling firm
Teva Pharmaceuticals USA, Inc
NDC code
0480-9262-08
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0406-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Octreotide recalls

See all